Drug Trial Radar · NCT07830732
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
84
Planned (sponsor's estimate)
Start
Oct 16, 2026
Primary completion
Mar 23, 2029
Study completion Mar 23, 2029
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Sep 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find out if denecimig is safe and effective for treating people who have acquired haemophilia A. Participants will be in this study for up to around 1 year and 5 months (73 week).
Conditions
- Haemophilia A
Interventions
DenecimigDrug
Participants will receive subcutaneous (s.c.) injections of denecimig.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of treated bleedsTime frame: From treatment initiation (week 0) until end of main part (week 12)
Locations
83 sites in 18 countries. Site status is shown where the registry gives one.
University of Iowa_Iowa City
Iowa City, Iowa · Not yet recruiting
Tulane University School of Medicine
Metairie, Louisiana · Not yet recruiting
University of Minnesota
Minneapolis, Minnesota · Not yet recruiting
Mayo Clinic
Rochester, Minnesota · Not yet recruiting
Washington University
St Louis, Missouri · Recruiting
University of North Carolina
Chapel Hill, North Carolina · Not yet recruiting
Duke University_Durham
Durham, North Carolina · Not yet recruiting
University of Oklahoma Health
Oklahoma City, Oklahoma · Not yet recruiting
Penn State MS Hershey Med Ctr
Hershey, Pennsylvania · Not yet recruiting
Univ of Pennsylvania Hospital
Philadelphia, Pennsylvania · Not yet recruiting
UT Southwestern
Dallas, Texas · Not yet recruiting
Univ Texas HSC-Houston
Houston, Texas · Not yet recruiting
UT Health San Antonio
San Antonio, Texas · Not yet recruiting
University of Utah Health
Salt Lake City, Utah · Not yet recruiting
University of Vermont Med Ctr
Burlington, Vermont · Not yet recruiting
University of Virginia
Charlottesville, Virginia · Not yet recruiting
Virginia Cwealth Univ Richmond
Richmond, Virginia · Not yet recruiting
Washington Ctr Bleed Disorder
Seattle, Washington · Not yet recruiting
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Buenos Aires, Argentina · Not yet recruiting
Servicio de Hematologia - Hospital Italiano
Buenos Aires, Argentina · Not yet recruiting
Instituto de Hematologia DR.Ruben Davoli
Rosario, Santa Fe Province, Argentina · Not yet recruiting
Royal Prince Alfred Hospital - Department of Haematology
Camperdown, New South Wales, Australia · Not yet recruiting
Royal Brisbane and Women's Hospital - Integrated Cancer Research (I-CARE)
Herston, Queensland, Australia · Not yet recruiting
The Alfred - Cancer Trials
Melbourne, Victoria, Australia · Not yet recruiting
Hemorio-Fundarj
Rio de Janeiro, Brazil · Not yet recruiting
Hospital Samaritano Higienópolis - Instituto de Conhecimento Ensino e Pesquisa (ICEP)
São Paulo, Brazil · Not yet recruiting
Hemocentro UNICAMP
Distrito de Barão Geraldo - Campinas, São Paulo, Brazil · Not yet recruiting
Unidade de Pesquisa Clínica do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Ribeirão Preto, São Paulo, Brazil · Not yet recruiting
Hospital das Clínicas da Faculdade de Medicina da USP
São Paulo, São Paulo, Brazil · Not yet recruiting
St Pauls Hospital
Vancouver, British Columbia, Canada · Not yet recruiting
McMaster University
Hamilton, Ontario, Canada · Not yet recruiting
St. Michael's Hospital
Toronto, Ontario, Canada · Not yet recruiting
Skejby Blodsygdomme, blødercentret
Aarhus N, Denmark · Not yet recruiting
HCL - HOPITAL LOUIS PRADEL - Unité d'hémostase Clinique
Bron, France · Not yet recruiting
HOPITAL DE BICETRE_Centre de l'Hémophilie
Le Kremlin-Bicêtre, France · Not yet recruiting
INSTITUT COEUR POUMON_Service d'hémostase et transfusion
Lille, France · Not yet recruiting
CHU DE NANTES-HOPITAL HOTEL-DIEU_Centre régional de traitement de l'Hémophilie
Nantes, France · Not yet recruiting
Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain
Berlin, Germany · Not yet recruiting
Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie
Bonn, Germany · Not yet recruiting
Medizinische Hochschule Hannover - Hämatologie, Hämostaseologie, Onkologie
Hanover, Germany · Not yet recruiting
Showing 40 of 83 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.